Over 4,000 residents of South Korea recovered from COVID-19 will donate blood plasma for developing a new treatment for coronavirus infection. According to estimates, the amount of blood will be about 83 billion US dollar worth if the 4,000 patients donate 500ml individually.
“It is difficult to accelerate developing a medicine for COVID-19 with only 200 recovered patients who expressed their will to donate blood. The massive donation from the recovered patients will solve the problem of the lack of blood for research,” said an official from Green Cross Pharma, a biopharmaceutical company in South Korea.
Earlier, the Chinese company China National Biotec Group (CNBG), which was developing two potential vaccines for coronavirus, said in a statement on optimistic results of testing one of them in humans. The vaccine has proven to be effective and safe, as all 1,120 volunteers in clinical trials successfully produced high-titer antibodies against COVID-19 after accepting the vaccine.